# Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

> **NCT05381870** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 48 (estimated)

## Conditions studied

- Pharmacokinetics
- Safety

## Interventions

- **BEHAVIORAL:** Test Preparation-Reference preparation
- **BEHAVIORAL:** Reference preparation-Test Preparation

## Key facts

- **NCT ID:** NCT05381870
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-26
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-12-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05381870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05381870, "Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05381870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*